FIELD: medicine.
SUBSTANCE: invention refers to 3 - (2-methoxy-4-pyrazol-1-ilfenil) -2,5-dimethyl-7-(3-methylpyridine-2-yl) pyrazolo [1.5-a] pyrimidine 
or its pharmaceutically acceptable salts, solvate, stereoisomer, having the following structural formula, which are antagonists of CRF-receptors and can be used in treatment of various disorders that cause hypersecretion of CRF in warm-blooded animals, such as at the sudden attack. Also the invention refers to intermediate compounds, pharmaceutical compositions on the basis of this compound and method of treating disorder causing hypersecretion of CRF in mammals.
EFFECT: improvement of composition.
15 cl, 14 tbl, 28 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HALOGENALLILAMINE DERIVATIVES AND THEIR APPLICATIONS | 2020 |
|
RU2793850C2 |
| IAP INHIBITORS | 2005 |
|
RU2401840C2 |
| DERIVATIVES OF BENZIMIDAZOLIDINONE AS AGENTS FOR MUSCARINIC RECEPTORS | 2002 |
|
RU2288919C2 |
| CALPAIN MODULATORS AND THEIR THERAPEUTIC USE | 2017 |
|
RU2773288C2 |
| AMINO-SUBSTITUTED ETHYLAMINO-AGONISTS OF β-ADRENERGIC RECEPTORS | 2004 |
|
RU2385317C2 |
| ANTIFIBROUS PYRIDINONES | 2015 |
|
RU2692485C2 |
| PRODRUGS OF OPIOID RECEPTOR ANTAGONISTS | 2018 |
|
RU2785777C2 |
| IAP INHIBITORS | 2013 |
|
RU2728789C2 |
| COMPOUNDS INHIBITING (BLOCKING) BITTER TASTE, METHODS FOR USE AND PRODUCTION THEREOF | 2008 |
|
RU2522456C2 |
| P38 INHIBITORS AND APPLICATION METHODS | 2004 |
|
RU2357957C2 |
